Antipsychotic Cuts Alzheimer's-Related Agitation

The antipsychotic brexpiprazole effectively improves agitation associated with Alzheimer's disease with favorable tolerability, results of a phase 3 study suggest.
Medscape Medical News

source https://www.medscape.com/viewarticle/989389?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost